Emerging evidence has shown that noncoding RNAs, particularly microRNAs (miRNAs), contribute to the pathogenesis of mood and anxiety disorders, although the molecular mechanisms are poorly understood. Here, we show that altered levels of miR-17-92 in adult hippocampal neural progenitors have a significant impact on neurogenesis and anxietyand depression-related behaviors in mice. miR-17-92 deletion in adult neural progenitors decreases neurogenesis in the dentate gyrus, while its overexpression increases neurogenesis. miR-17-92 affects neurogenesis by regulating genes in the glucocorticoid pathway, especially serum-and glucocorticoid-inducible protein kinase-1 (Sgk1). miR-17-92 knockout mice show anxiety-and depression-like behaviors, whereas miR-17-92 overexpressing mice exhibit anxiolytic and antidepression-like behaviors. Furthermore, we show that miR-17-92 expression in the adult mouse hippocampus responds to chronic stress, and miR-17-92 rescues proliferation defects induced by corticosterone in hippocampal neural progenitors. Our study uncovers a crucial role for miR-17-92 in adult neural progenitors through regulation of neurogenesis and anxiety-and depression-like behaviors.
INTRODUCTION
Mood and anxiety disorders are known to be associated with many risk factors, such as environmental, genetic, and epigenetic ones, making investigation of the pathophysiology of these disorders extremely challenging (Krishnan and Nestler, 2008) . Antidepressants are used for the treatment of both depression and anxiety disorders, but only 30%-50% of patients show amelioration (Gaynes et al., 2008) . Thus, it is essential to better understand the etiology of the disorders and to develop new targets for improved therapies.
The dentate gyrus (DG) in the hippocampus is one of the neurogenic zones in the adult brain. The DG is populated by neural stem cells and neural progenitors and is continuously generating new neurons (Ming and Song, 2011; Zhao et al., 2008) . The impact of adult neurogenesis in the function of hippocampus has drawn significant attention (Deng et al., 2010; Jacobs et al., 2000; Kheirbek et al., 2012; Sahay and Hen, 2007) . While some studies demonstrate the association of adult neurogenesis with depression and anxiety (Kheirbek et al., 2012; Sahay and Hen, 2007) , other reports show inconsistent outcomes . Even though the neurogenic theory of depression and anxiety appears controversial, it is still plausible and holds possibility for the adult hippocampal neurogenesis as a therapeutic means for mood and anxiety disorders Hill et al., 2015; Miller and Hen, 2015) . Thus, there is an unmet need for research to identify molecules that regulate both hippocampal neurogenesis and depression-and anxiety-like behaviors.
MicroRNAs (miRNAs) normally silence protein-coding target genes and play crucial roles in many aspects of neural development and neurological disorders (Bian and Sun, 2011; Fineberg et al., 2009; Kosik, 2006; Qureshi and Mehler, 2012) . Recent studies have begun to reveal the contribution of miRNAs in the pathogenesis of mood and anxiety disorders (Issler et al., 2014; Lopez et al., 2014; Malan-M€ uller et al., 2013; Xu et al., 2012) . However, little is known about specific miRNAs being involved in the regulation of adult hippocampal neurogenesis and/or mood and anxiety behaviors.
The miR-17-92 cluster has been shown to be involved in embryonic brain development and tumorigenesis (Bian et al., 2013; Olive et al., 2010) . In this study, we identified the miR-17-92 cluster highly expressed in the adult mouse hippocampus. We found that miR-17-92 regulates adult hippocampal neurogenesis and mood and anxiety-related behaviors in mice. We further established the regulatory role of miR-17-92 in modifying genes in the glucocorticoid pathway including Sgk1 and rescuing reduced proliferation, caused by corticosterone, in hippocampal progenitors. Our studies indicate that the miR-17-92 cluster is a pivotal regulator of adult hippocampal neurogenesis and anxiety-and depression-like behaviors.
RESULTS
Altering Adult Hippocampal Expression of miR-17-92 in miR-17-92 KO and OE Mice Previous studies suggested a role of the miR-17-92 cluster in embryonic neural stem cell development and proliferation of cancer cells (Bian et al., 2013; Olive et al., 2010) , but its involvement in adult brain neurogenesis and function is unknown. Transcription of the miR-17-92 cluster generates six miRNAs that can be grouped into four subfamilies (Mendell, 2008), miR-17 (and miR-20a), miR-18a, miR-19a (and miR19b) , and miR-92a, based on their conserved sequences (Figure 1A) . To examine expression patterns of miR-17-92, we performed in situ hybridization in 12-week-old adult mouse brains by using locked nucleic acid (LNA) probes for miR-17 (that also recognizes 20a), miR-19a (that also recognizes 19b) , and miR-92a. All three subfamilies of the miRNA were expressed in the adult hippocampus and in the cortex ( Figure 1B ).
Because miR-17-92 has been shown to regulate proliferation in embryonic neural stem cells and cancer cells (Bian et al., 2013; Olive et al., 2010) , we speculated that they might be involved in adult hippocampal neurogenesis and function. To examine the possible role for miR-17-92 in maintaining progenitor cells in the adult hippocampus, we generated conditional miR-17-92 knockout (miR-17-92 KO) mice and miR-17-92 overexpressing (miR-17-92 OE) mice. We utilized a Nestin-CreER line (Kuo et al., 2006) , in which the Cre recombinase is expressed in neural progenitors in the adult brain upon tamoxifen injection. The Nestin-CreER mice were bred with floxed miR-17-92 KO mice (Ventura et al., 2008) or floxed miR-17-92 overexpressing mice (Xiao et al., 2008) , and tamoxifen was injected at the age of 5 weeks ( Figures 1C, 1D , and S1A). To test altered miR-17-92 expression, real-time qRT-PCR was performed. Expression levels of miR-17, miR-18, miR-19a, and miR-92 were decreased in hippocampus of miR-17-92 KO mice, while they were increased in hippocampus of miR-17-92 OE mice, suggesting expected alteration of miR-17-92 in the adult hippocampus ( Figures S2A and S2B) . -17 (miR-20a), miR-19a (miR-19b) , and miR-92a were expressed in the 12-week-old adult mouse hippocampus (Hp) and cortex (Cx). (C and D) Generation of miR-17-92 knockout (KO) and miR-17-92 overexpressing (OE) mice using the Nestin-CreER line. (E) The whole brain images of wild-type (WT), miR-17-92 KO and OE mice showed normal brain morphology ( Figure 1E ). In addition, miR-17-92 KO mice displayed slightly reduced body weight but normal brain weight compared to wild-type control littermates ( Figure 1F ). miR-17-92 OE mice were indistinguishable from controls in brain and body weights ( Figure 1F ). Furthermore, we measured the thickness of the cortical wall and found no difference among control, miR-17-92 KO, and OE mice ( Figures S2C-S2E ). These results suggest that altered miR-17-92 expression in neural progenitors in the adult brain has minimal effects on brain and body growth.
Adult Hippocampal Neurogenesis Is Altered in miR-17-92 KO and OE Mice Even though brain weights were not changed in miR-17-92 KO and OE mice, altered miR-17-92 expression might affect neurogenesis in the adult hippocampus. We thus investigated generation of adult hippocampal neural progenitors and newborn neurons in miR-17-92 KO and OE mice. To detect proliferative neural progenitors, bromodeoxyuridine (BrdU) was administered in the 12-week-old mice, 6 days before brain tissue collection ( Figure S1A ). The number of BrdU + cells was reduced in the dentate gyrus of the miR-17-92 KO hippocampus (Figures 2A and  2B ), but increased in OE mice ( Figures 2C and 2D) . Moreover, the number of cells expressing Ki67, which indicates progenitors in the G1, S, G2, and M phases of the cell cycle, also was decreased in the miR-17-92 KO (Figures 2E and 2F) but increased in the OE hippocampus ( Figures 2G and 2H ). These results indicate that miR-17-92 function is required for maintaining proliferative neural progenitors in the adult hippocampus.
We also examined the number of Doublecortin (Dcx)-expressing newborn neurons. Consistent with changes in the number of neural progenitors, the number of Dcx + cells was reduced in the DG of the miR-17-92 KO hippocampus ( Figures 2I and 2J ), but increased in OE mice (Figures 2K and 2L) , suggesting that generation of newborn neurons is impaired. Moreover, the number of BrdU + or NeuN + /BrdU + cells at 13 weeks old, which were labeled by BrdU injection at 7 weeks old to detect newborn neurons (Figure S1B) , also was decreased in the miR-17-92 KO hippocampus ( Figures S3A and S3B ). Taken together, our results indicate that miR-17-92 is required to maintain proliferative neural progenitors and to generate new neurons in the adult hippocampus.
miR-17-92 KO and OE Mice Exhibit Elevated Anxiety-like or Anti-anxiety-like Behaviors Previous studies have shown that adult hippocampal neurogenesis is associated with mood and anxiety disorders Miller and Hen, 2015) . Because altered expression of miR-17-92 caused changes in hippocampal neurogenesis, we examined whether anxiety-related behaviors are affected in miR-17-92 KO and OE mice ( Figure S1C) . In the open field test, miR-17-92 KO mice and OE mice showed comparable locomotor activity as measured by total distance compared to their wild-type controls ( Figure S3C ). However, miR-17-92 KO mice displayed markedly less frequency of stay, less time spent, and less distance moved in the center of the open field compared to wildtype controls ( Figure 3A ). On the other hand, miR-17-92 OE mice exhibited opposing behaviors ( Figure 3B ). Moreover, in the elevated plus maze test, miR-17-92 KO mice showed significantly less duration and less distance traveled in open arms (Figure 3C) , while miR-17-92 OE mice showed a significantly greater frequency of stay and longer total distance moved in open arms ( Figure 3D ). These results indicate that miR-17-92 deletion or Figure 3E ). In the tail-suspension test, the immobility time was also increased in miR-17-92 KO mice, suggesting that miR-17-92 KO mice exhibit elevated depression-like behaviors ( Figure 3F ). Moreover, in the sucrose preference test, miR-17-92 KO mice showed reduced intake of sucrose, suggesting anhedonia-like behavior ( Figure 3G S1D ). We identified 504 genes significantly altered in the hippocampus of miR-17-92 KO mice (false discovery rate <0.1). Among them, 229 genes were upregulated, suggesting that they are usually directly or indirectly silenced by miR-17-92, and 78 out of 229 genes were predicted targets of miR-17-92 (Table S1 ). Gene ontology (GO) analyses of the 504 genes with altered expression in miR-17-92 KO hippocampus revealed that many of them regulate cell proliferation and differentiation ( Figure S4A ). This finding is consistent with the function associated with the 229 upregulated genes, including predicted targets of the miR-17-92 cluster ( Figure S4B ). Moreover, using four target prediction tools (Targetscan, miRDB, DIANA-microT, and TarBase), we identified 150 genes, which are either up-or downregulated, as predicted targets of the miR-17-92 cluster (Table S1 ). Interestingly, a detailed GO analysis of the 150 predicted target genes revealed their involvement in glucocorticoid-related functions in the absence of miR-17-92 ( Figure 4B ). Among them, the kinase Sgk1 (Lang et al., 2010) was found to have a significant upregulation in the miR-17-92 KO hippocampus (1.3 fold increase) and to be involved in six out of the top ten predictable major biological functions that are associated with the 150 target genes ( Figure 4B ). Sgk1 is known as a downstream effector of the glucocorticoid receptor (GR) (Anacker et al., 2013) . Functional interaction analysis of Sgk1 with 504 genes that showed altered expression in the miR-17-92 KO hippocampus further indicated that Sgk1, as a crucial modulator in the glucocorticoid pathway, interacts with genes directly involved in cell-cycle control, developmental process, and neurogenesis ( Figure 4C ). Our results indicate the regulatory effect of the miR-17-92 cluster on the glucocorticoid pathway. 
The Expression Level of Sgk1 Is Specifically Increased in miR-17-92 KO Hippocampus
To further test whether Sgk1 is a target of the miR-17-92 cluster, we searched the Sgk1 3 0 UTR, where miRNAs typically bind to silence target gene expression. We found that Sgk1 3 0 UTR contains binding sites for miR-19a and miR-92a ( Figure 5A ). We cloned the Sgk1 3 0 UTR into a luciferase vector. When the Sgk1 3 0 UTR-luciferase was co-expressed with miR-19a or miR-92a, wild-type, but not their mutants, significantly reduced the relative luciferase activity, suggesting that miR-19a and miR-92a have specific targeting effects on the Sgk1 3 0 UTR ( Figure 5B ).
We next examined the expression of Sgk1 in the DG of 13-week-old wild-type and miR-17-92 KO mice. Scattered Sgk1 + cells were observed in the subgranular zone (SGZ) and the granule cell layer (GCL) in the DG of wild-type and miR-17-92 KO hippocampus ( Figure 5C ). Interestingly, the number of Sgk1 + cells was significantly increased in the SGZ in miR-17-92 KO mice ( Figures 5D and 5E ). Moreover, Sgk1 + cells were Figure S5 .
also detected in the polymorphic layer (PML) (Scharfman and Myers, 2013) , the area between the upper and lower GCLs ( Figure S5A ). The number of Sgk1 + cells also was increased in the PML in miR-17-92 KO mice ( Figures S5B and S5C) . However, the number of cells expressing GR, an upstream gene of Sgk1 (Anacker et al., 2013) , did not show significant difference in the DG of control and miR-17-92 KO mice ( Figures S5D and S5E Figure 6A ). In addition, Sgk1 expression was not detected in the prefrontal cortex and hypothalamus ( Figures 6B and 6C) . Moreover, the overall neurogenesis, labeled by NeuN + cells, also did not show significant changes in the amygdala, prefrontal cortex, and hypothalamus ( Figure 6 ). Our results suggest that elevated expression of Sgk1 in the hippocampus in miR-17-92 KO mice is brain region specific.
miR-17-92 Rescues Stress-Induced Proliferation Defect in Hippocampal Neural Progenitors
A large body of studies has shown that chronic stress alters the release of adrenal glucocorticoid hormones and in turn affects hippocampal neurogenesis and has a detrimental influence on learning and memory and mood behaviors (Joë ls, 2008; McEwen, 2001; Saaltink and Vreugdenhil, 2014; Schoenfeld and Gould, 2012 ). Because we found that miR-17-92 regulates the glucocorticoid pathway, we next examined whether chronic stress also has a direct effect on miR-17-92 expression in the hippocampus. Eight-week-old mice were subjected to restraint stress for 2 weeks, while being administered an antidepressant (antidep) fluoxetine or vehicle as a control . Consistent with previous reports (Anacker et al., 2013; Saaltink and Vreugdenhil, 2014) , expression levels of GR and Sgk1 were increased due to stress and rescued by antidepressant treatment (Figure S6A) . On the contrary, chronic stress significantly reduced expression levels of miR-17, miR-18, miR-19a, and miR-92a in the hippocampus, compared to their controls, and the reduction was prevented by antidepressant treatment ( Figure S6B ). These results suggest that hippocampal expression of miR-17-92 is responsive to chronic stress and antidepressant.
To further test the effect of miR-17-92 on proliferation of hippocampal neural progenitors under stress treatment, we used HT-22 cells, which are immortalized mouse hippocampal Scale bars, 100 mm. DAPI (blue), Sgk1 (green), and NeuN (red) were labeled. All data were presented as means ± SEM. A two-tailed, unpaired Student's t test was used for comparisons.
neurons (Davis and Maher, 1994) . HT-22 cells were treated with corticosterone (CORT) and the vehicle control (Malviya et al., 2013) and were then transfected with the pCAGIG vector containing a GFP reporter gene and pulsed with BrdU for 2 hr. CORT-treatment significantly reduced BrdU + /GFP + cells, compared to the vehicle control ( Figures S6C and S6D) . Furthermore, miR-19a and miR-92a precursors were cloned into the pCAGIG vector and transfected into CORT-treated HT-22 cells (Bian et al., 2013 (Boldrini et al., 2009; Malberg et al., 2000) . We then tested whether antidepressant-regulated neurogenesis is mediated by miR-17-92. Wild-type control and miR-17-92 KO mice were administered the antidepressant fluoxetine for 2 weeks. Consistent with previous reports, elevated neurogenesis was observed in control and miR-17-92 KO hippocampus ( Figures 7A-7C) . However, the degree of increased neurogenesis was significantly restrained by miR-17-92 knockout ( Figure 7D ).
Furthermore, studies have shown that chronic stress has a negative effect on hippocampal neurogenesis (Joë ls, 2008; McEwen, 2001; Saaltink and Vreugdenhil, 2014; Schoenfeld and Gould, 2012) . We next examined whether overexpression of miR-17-92 protects stress-induced decrease of adult hippocampal neurogenesis. Wild-type control and miR-17-92 OE mice at 8 weeks old were subjected to restraint stress for 2 weeks . While stress caused a reduction in neurogenesis in the control hippocampus, its effect on miR-17-92 OE hippocampus was subtle, suggesting that overexpression of miR-17-92 rescues stress-induced neurogenesis defect ( Figures  7E-7H ).
Sgk1 Expression Displays an Opposite Change Compared to Hippocampal Neurogenesis upon Antidepressant and Stress Treatment
If miR-17-92-mediated adult hippocampal neurogenesis is partly regulated through their target gene Sgk1, changes in Sgk1 expression and neurogenesis should be opposite. We examined Sgk1 expression in the hippocampus of wild-type control and miR-17-92 KO mice that are administered the antidepressant fluoxetine. In the control hippocampus treated with antidepressant, the number of Sgk1 + cells was not altered compared to untreated ( Figure S7A ). Moreover, while antidepressant treatment resulted in an increased neurogenesis ( Figures 7A-7D) , it caused decreased number of Sgk1 + cells in miR-17-92 KO hippocampus, compared to untreated miR-17-92 KO ( Figure S7A ).
Furthermore, while chronic stress caused a decreased neurogenesis in the control hippocampus ( Figures 7E-7H) , it caused an increase in the number of Sgk1 + cells ( Figure S7B ). Interestingly, in miR-17-92 OE mice treated with stress, miR-17-92 overexpression prevented a reduction in neurogenesis ( Figures 7E-7H ), it caused a decrease in the number of Sgk1 + cells, which further suggests a silencing effect of miR-17-92 on Sgk1 expression ( Figure S7B ). Moreover, miR-17-92 knockout caused a dramatic increase in the number of Sgk1 + cells in the hippocampus of miR-17-92 KO mice ( Figure S7B ). These results indicate miR-17-92 targeting effect on Sgk1 in vivo.
Because increased neurogenesis and decreased Sgk1 expression were detected in the hippocampus of miR-17-92 KO mice treated with antidepressant, we further examined the behavioral outcome. The forced swim test and tail suspension test were performed in miR-17-92 KO mice treated with vehicle and antidepressant. miR-17-92 KO mice treated with antidepressant displayed reduced immobility time in both tests, compared to those treated with vehicle, suggesting that antidepressant treatment has a rescue effect on depression-like behaviors in miR-17-92 KO mice ( Figures S7C and S7D ).
DISCUSSION
Identification of specific molecules that regulate anxiety-and depression-like behaviors would contribute to our better understanding of pathophysiology of mood and anxiety disorders. In this study, we have shown that miRNAs in the miR-17-92 cluster are highly expressed in the adult mouse hippocampus. Importantly, deletion or overexpression of miR-17-92 in adult neural progenitors causes decreased or increased hippocampal neurogenesis, resulting in elevated anxiety-and depression-like behaviors, or anxiolytic and antidepression-like behaviors, respectively. Our results suggest a molecular mechanism by which miRNAs are associated with adult hippocampal neurogenesis and mood and depression-like behaviors.
Adult hippocampal neurogenesis requires multiple steps, including proliferation of neural progenitors, differentiation to neurons, and survival of newborn neurons (Ming and Song, 2011; Zhao et al., 2008) . Our results have shown that miR-17-92 plays a role in the maintenance of proliferative neural progenitors and the generation of newborn neurons. The role for miR-17-92 in the proliferation of neural progenitors in the adult hippocampus is consistent with its demonstrated function in the maintenance of embryonic neural stem cells and the proliferation of various cancer cells (Bian et al., 2013; Olive et al., 2010) . We have found that miR-17-92 knockout causes a reduction of antidepressantinduced increase in neurogenesis, while miR-17-92 overexpression is resistant to stress-induced reductions in neurogenesis, indicating a direct role of miR-17-92 in regulating hippocampal neurogenesis. Moreover, here, we have identified that the expression levels of multiple genes, known to be involved in cell proliferation and differentiation, are altered in the hippocampus of miR-17-92 KO mice. Particularly, the alterations in the level of multiple genes that are implicated in glucocorticoid-mediated pathways are also observed in the hippocampus of miR-17-92 KO mice. Because glucocorticoid and its signaling are known to affect adult hippocampal neurogenesis (Joë ls, 2007), altered expression of target genes for miR-17-92 in glucocorticoid pathways may be responsible for impaired adult neurogenesis in miR-17-92 KO mice. Future studies should address which target genes for miR-17-92 contribute to which specific steps of the adult neurogenesis.
Recent studies have suggested an involvement of miRNAs in the regulation of anxiety-and depression-like behaviors. miR-16 was found to play a role in the actions of the selective serotonin reuptake inhibitor (SSRI) by targeting the serotonin transporter in serotonergic and noradrenergic neurons (Baudry et al., 2010) . miR-135 was shown to target serotonin transporter and serotonin receptor-1a in the serotonergic neurons and regulate anxiety-and depression-like behaviors and behavioral response to antidepressant treatment (Issler et al., 2014) . miR-18 might negatively regulate the glucocorticoid pathway (Shimizu et al., 2015; Vreugdenhil et al., 2009) . Glucocorticoid is associated with stress-induced anxiety and mood behaviors (McEwen, 2001; Pace and Miller, 2009 ). Previously, the increased level of Sgk1 was observed in peripheral blood of depressed patients (Anacker et al., 2013) . In this study, we have identified Sgk1 as a direct target of miR-19a and miR-92a in the miR-17-92 cluster in vitro and in vivo. The increased Sgk1 expression, as a result of miR-17-92 deletion, was observed in the SGZ of the DG, but not in other brain regions. It is possible that the effects of miR-17-92 deletion in hippocampal neurogenesis and mouse behaviors are, at least in part, mediated by increased Sgk1.
Furthermore, although we observed a correlation between the altered hippocampal neurogenesis and behavioral phenotypes in miR-17-92 KO or OE mice, the connection of adult hippocampal neurogenesis to anxiety-and depression-like behaviors remains controversial Samuels and Hen, 2011; Snyder et al., 2011) . Nevertheless, because miRNAs are useful tools for the treatment of mood and anxiety disorders (O'Connor et al., 2012) , the causal relationship observed in this study between altered levels of miR-17-92 and anxiety-and depression-like behaviors suggests that the miR-17-92 cluster has potential as a therapeutic target for these disorders.
EXPERIMENTAL PROCEDURES Transgenic Mouse Lines
To delete the miR-17-92 cluster in the adult mouse brain, floxed miR-17-92 transgenic mice (Ventura et al., 2008) :Nestin-CreER. miR-17-92 KO mice were generated after the injection of tamoxifen. To overexpress the miR-17-92 cluster in the adult brain, we employed transgenic mice with a floxed stop codon in front of the miR-17-92 transgene (Xiao et al., 2008) . Once bred with the Nestin-CreER line, the overexpression of the miR-17-92 cluster was induced by tamoxifen, called here miR-17-92 overexpressing (OE) mice. Wild-type mice used in this project were mice that carry homozygote floxed alleles but are Cre-negative. Tamoxifen was administered all genotyping mice to avoid tamoxifen drug effect.
Transgenic animals were maintained at the facility of Weill Cornell Medical College. Animal use was overseen by the Animal Facility and approved by the Institutional Animal Care and Use Committee (IACUC) at the Weill Cornell Medical College. Experiments with chronic restraint stress were performed at The Rockefeller University, and the experimental procedure was approved by The Rockefeller University Institutional Animal Care and Use Committee and was in accordance with guidelines of the NIH.
RNA-Seq
The adult hippocampi of the 13-week-old mice were dissected from three wildtype and three miR-17-92 KO mice, each of them from a different litter. Total RNA was extracted and purified using the RNeasy mini kit with optional on-column DNase digestion (QIAGEN). Whole RNA-seq was performed at the Weill Cornell Genomics Core Facility using an IlluminaHiseq 1000.
Statistics
All data were shown as means ± SEM. Two group comparisons were done by two-tailed, unpaired Student's t test. The influence of drug and stress treatment was assessed using two-way ANOVA with Bonferroni's post hoc tests.
Additional experimental procedures and associated references are available in the Supplemental Experimental Procedures.
ACCESSION NUMBERS
The accession number for the RNA-seq data from the adult hippocampus of wild-type and miR-17-92 knockout mice reported in this paper is GEO: GSE83636. (E) The number of GR + cells didn't show significant difference between WT and miR-17-92
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Scale bars, 100μm. DAPI (blue) was used to label nucleus. All data were presented as means ± s.e.m. n=6 per group. ***p < 0.001, compared to WT controls, using a two-tailed unpaired Student's t-test. (A and B) 8 weeks old mice were subjected to restraint stress for 2 weeks, while being administered an antidepressant fluoxetine (Stress + antidep), or saline (Stress). Control mice (Ctrl) were not exposed to the restraint stress but were administered saline for 2 weeks.
Expression levels of GR, Sgk1 (A), and miR -17, miR-18a, miR-19a and miR-92a (B) Values plotted were means ± s.e.m. *: p < 0.05, **: p < 0.01 and ***: p < 0.001, compared to Ctrl, Stress, pCAGIG, or CORT Controls, using a two-tailed, unpaired Student's t-test. Values plotted were means ± s.e.m. *: p < 0.05, **: p < 0.01 and n.s.: not significant, using a two-tailed, unpaired Student's t-test.
Mouse genotyping
For mouse genotyping, mouse tail-tip biopsies were used for PCR reactions using the 
Tamoxifen injection
Tamoxifen (Sigma, T5648-1G) was dissolved in corn oil/100% ethanol mixture (9:1, 5mg tamoxifen/40g body weight), and was administered by intraperitoneal injection (i.p.) to the 5 weeks old mice once a day for 6 consecutive days. All genotyping mice were administered tamoxifen before analyses.
BrdU pulse
5-bromo-2-deoxyuridine (BrdU, 50mg/g body weight) was administered by i.p. to the 7 weeks old mice once a day for 6 days, or to the 12 weeks old mice once a day for 6 days.
Histology and immunohistochemistry
Mouse brains were perfused and fixed with 4% paraformaldehyde (PFA) in phosphate-buffered saline (PBS) at 4 ℃ overnight, then incubated in 30% sucrose in PBS at 
Cell counting and statistical analysis in the dentate gyrus
Coronal sections covering the whole dentate gyrus were collected from the anterior to posterior region. For cell counting analysis, we used same method described in the previous publication . Briefly, we collected at least 6 animals for each genotype and counted 6 serial coronal sections in each brain. The total number for each marker of neurogenesis was the sum of all positive cells in the dentate gyrus of all sections from 6 brains. And 6 summed values were averaged in each genotype. Statistical analysis was conducted using Student's t test or two-way ANOVA, and the mean ± s.e.m. is shown in the graph.
miRNA in situ hybridization
16
In situ hybridization for miRNA expression was performed on frozen sections according to previously published methods with modifications using locked nucleic acid (LNA) probes (Obernosterer et al., 2007) . Briefly, the miR-17, miR-19a and miR-92a LNA probes (Exiqon) were 3' end labeled with DIG-ddUTP. After fixation with 4% PFA, acetylation with the acetylation buffer (13.33% Triethanolamine, 2.5% Acetic anhydride, 20 mM HCl), treatment with proteinase K (10 mg/ml, IBI Scientific) and pre-hybridization 
Mutagenesis
The mutant miRNAs were generated using QuikChange II Site-Directed Mutagenesis 
Luciferase assays
Neuro2a cells were transfected using Lipofectamine 2000 (Invitrogen) using the manufacturer's protocol. Plasmids were quantified by the UV spectrophotometry and used for transfection in a 2:1 ratio (miRNA: target luciferase constructs). pGL4.13 Firefly luciferase (Promega) was used for 3'UTRs of targets. pGL4.73 renilla luciferase (Promega) was used as a transfection control. Luciferase activity was measured using the Dual-Luciferase Reporter Assay kit (Promega) using the manufacturer's protocol and read on a Victor3 1420 multilabel counter (Perkin Elmer). All conditions were run in triplicate. All experiments were repeated 18 at least once, and results were similar. To adjust transfection variation, raw results of Firefly luciferase activities were first normalized by dividing the Firefly luciferase activity by the Renilla luciferase activity. The luciferase activities were presented as relative values to the average value of the empty vector (pcDNA) and pcDNAs luciferase activity value was normalized as 1.
Locomotion test
Locomotor activity was evaluated in an open field (45 x 45 cm; height 20 cm). Each mouse was placed in the center of the field. The total distance moved was recorded every 10 minutes for 60 minutes using a video tracking system (Oh et al., 2009) 
Restraint stress test
Mice were individually placed head-first into well-ventilated 50 ml polypropylene conical tubes, which were then plugged with a 4.5-cm-long middle tube, and finally tied with a cap of the 50 ml tube . After 2 hours of restraint, the mice were returned to their home cage, in which they were housed in pairs in normal plastic cages with free access to food and water. The mice were treated with stress for 2 weeks.
Antidepressant administration
Mice were administrated daily fluoxetine (20 mg/kg, i.p., Sigma-Aldrich) or vehicle for 2 weeks until the day before the experiment. Fluoxetine was dissolved in
Function enrichment analysis
Mosaic version 1.1 was used to retrieve gene ontology (GO) information for all genes of the mouse genome (Zhang et al., 2012 150 predicted targets for miR-17-92 were analyzed further to obtain specific biological functions. A Cytoscape app, NOA ) (version 1.1) was used with GO-pir from the protein information resource (Wu et al., 2003) . In order to control the type I error rate of multiple hypotheses testing, the Benjianmini & Hochberg method was employed to adjust p-values by using 0.05 as the level of significance, so any test with p<0.05 was considered statistically significant.
To reveal the role of Sgk1 in the adult hippocampus, the 15 most relevant biological process functions, detected by GO analyses, were selected to create a function map. Each node is one function or a set of genes with this function. The size of each node represents the number of DEGs with this function. Links between two nodes mean that these two gene sets are significantly overlapped (they share some common genes, and based on the fisher's exact 22 test with Bonferroni correction, p<0.05). The color of node is the percentage of target genes (dark blue is around 21%, white is around 50%, and red is around 100%).
